000 | 01186 a2200313 4500 | ||
---|---|---|---|
005 | 20250515040355.0 | ||
264 | 0 | _c20070301 | |
008 | 200703s 0 0 eng d | ||
022 | _a0923-7534 | ||
024 | 7 |
_a10.1093/annonc/mdl181 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBerruti, A | |
245 | 0 | 0 |
_aManagement of the side-effects of intravenous bisphosphonates: targeting the serum parathyroid hormone elevation. _h[electronic resource] |
260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cDec 2006 |
||
300 |
_a1854-5 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypocalcemia _xchemically induced |
650 | 0 | 4 |
_aParathyroid Hormone _xblood |
700 | 1 | _aTucci, M | |
700 | 1 | _aGenerali, D | |
700 | 1 | _aMosca, A | |
700 | 1 | _aArdine, M | |
700 | 1 | _aVana, F | |
700 | 1 | _aDogliotti, L | |
773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 17 _gno. 12 _gp. 1854-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdl181 _zAvailable from publisher's website |
999 |
_c16521834 _d16521834 |